CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments.

MLA

Bernard-Valnet, Raphael, et al. “CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases’ Treatments.” Neurology(R) Neuroimmunology & Neuroinflammation, vol. 9, no. 1, Nov. 2021. EBSCOhost, https://doi.org/10.1212/NXI.0000000000001097.

APA

Bernard-Valnet, R., Moisset, X., Maubeuge, N., Lefebvre, M., Ouallet, J.-C., Roumier, M., Lebrun-Frenay, C., Ciron, J., Biotti, D., Clavelou, P., Godeau, B., Du Pasquier, R. A., & Martin-Blondel, G. (2021). CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases’ Treatments. Neurology(R) Neuroimmunology & Neuroinflammation, 9(1). https://doi.org/10.1212/NXI.0000000000001097

Chicago

Bernard-Valnet, Raphael, Xavier Moisset, Nicolas Maubeuge, Mathilde Lefebvre, Jean-Christophe Ouallet, Mathilde Roumier, Christine Lebrun-Frenay, et al. 2021. “CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases’ Treatments.” Neurology(R) Neuroimmunology & Neuroinflammation 9 (1). doi:10.1212/NXI.0000000000001097.